SAB Biotherapeutics, Inc. ( SABS) - Stock Earnings
SABS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
SABS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -16.9 million USD | — USD |
| 2026Q1 | -18.9 million USD | — USD |
| 2026Q2 | -22.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
SABS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -42.2 million USD | 2.2 million USD |
| 2024 | -34.1 million USD | 1.3 million USD |
| 2025 | 13.3 million USD | — USD |
| 2026 Est. | — | — |
SABS
Price: $2.53
Earnings Per Share: 0.24 USD
P/E Ratio: 15.67
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 35000
Market Capitalization: 271.1 million